Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
May 12, 2021     Contact    
Featured This Week
 
Vision Marine (Nasdaq: VMAR): Disrupting the Traditional Boating Industry with Electric Power
 

 


Vision Marine Technologies (Nasdaq: VMAR) strives to be a guiding force for change and an ongoing driving factor in fighting the problems associated with waterway pollution by disrupting the traditional boating industry with electric power, in turn directly contributing to zero pollution, zero emission and a noiseless environment. Our flagship outboard powertrain ("E-Motion") is the first fully electric purpose-built outboard powertrain system that combines an advanced battery pack, inverter, and high efficiency motor with proprietary union assembly between the transmission and the electric motor design utilizing extensive control software. Our E-Motion and related technologies used in this powertrain system are uniquely designed to improve the efficiency of the outboard powertrain and, as a result, enhance both range and performance. Vision continues to design, innovate, manufacture, and sell our handcrafted, high performance, environmentally friendly, electric recreational power boats to customers. The design and technology applied to our boats results in far greater enhanced performance in general, higher speeds, and longer range. Simply stated, a smoother ride than a traditional ICE motorboat.
Learn more at www.visionmarinetechnologies.com.

 
 >
Latest News
 
Kiromic (NASDAQ: KRBP) Announces 6 Posters Presented at American Association of Cancer Research 2021 Showcasing our Artificial Intelligence (AI) Biomarker Engine
 >
Annovis Bio (NYSE American: ANVS) Receives US Patent for Method of Treating Frontotemporal Dementia and Chronic Traumatic Encephalopathy
 >
Lantern Pharma (NASDAQ: LTRN) and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform
 
 
Lantern Pharma (NASDAQ: LTRN) Reports First Quarter 2021 Financial Results and Operational Highlights
 
 
Tiziana (NASDAQ: TLSA) Announces Strategic Initiative with Takanawa Japan K.K., Pharma Team, to Identify a Partner in Japan and Other Asian Countries for Further Clinical Development of Milciclib in Patients with Advanced Hepatocellular Carcinoma
 
 
Aptorum Group (NASDAQ: APM) Enters into an Agreement with Exeltis to Develop Aptorum's Novel Preclinical Candidate Targeting Woman's Gynecological Conditions
 
 
Virios Therapeutics (NASDAQ: VIRI) to Report First Quarter 2021 Financial Results and Provide Corporate Update on Thursday, May 13, 2021
 
 
Red Cat Holdings (NASDAQ: RCAT) Announces Closing of $16 Million Public Offering and Nasdaq Listing
 
 
Red Cat Holdings (NASDAQ: RCAT) Signs Letter of Intent to Acquire LuGus Studios
 
 
Amesite (NASDAQ: AMST) Expands Partnership with Michigan's Third-Largest Institution of Higher Learning, Wayne State University, Launching Special Advanced Technology Certificate Programs for High School Students
 
 
Esports Entertainment Group (NASDAQ: GMBL) Announces Participation in Noble Capital Markets C-Suite Interview Series
 
 
Esports Entertainment Group (NASDAQ: GMBL) to Accelerate Content Strategy with the Acquisition of Holodeck Media
 
 
Richard Carter joins Bragg Gaming (OTCQX: BRGGF) as Group CEO
 
 
Bragg Gaming (OTCQX: BRGGF) Announces First Quarter 2021 Earnings and Business Update Conference Call
 
 
Bragg Gaming (OTCQX: BRGGF) Signs Deal with Logrand Entertainment Group in Mexico
 
 
Hut 8 Mining (OTCQX: HUTMF) Announces Release Date for Q1 2021 Earnings: May 13th 2021
 
 
Nemaura Medical (NASDAQ: NMRD) Announces Order for 200,000 sugarBEAT® Sensors
 
 
Nemaura Medical (NASDAQ: NMRD) Announces Progress on Listing of sugarBEAT® For Reimbursement in Germany
 
 
1847 Goedeker (NYSE American: GOED) Announces Proposed Public Offering of Common Stock
 
 
Hoth Therapeutics (NASDAQ: HOTH) Announces Development of HT-KIT to Treat Multiple Orphan Diseases, Including Rare Cancers
 
 
Hoth Therapeutics (NASDAQ: HOTH) and Virginia Commonwealth University Expand Research Agreement for COVID-19 Therapeutic
 
 
SPI Energy’s (NASDAQ: SPI) Solar4America Launches Residential Battery Storage Solution
 
 
SPI Energy’s (NASDAQ: SPI) SolarJuice to Showcase its Expansive Product Range at Smart Energy 2021 Conference
 
 
Milestone Scientific (NYSE American: MLSS) Reports Preliminary Sales Results for Q1 2021; Revenue Increases 61% Over the Same Period Last Year
 
 
American Resources (NASDAQ: AREC) Selected as a Consortium Member in U.S. Department of Energy Contract to Assess Northern Appalachian Critical and Rare Earth Elements
 
 
American Resources (NASDAQ: AREC) Announces the Expansion of its Sponsored Research Program with Purdue University for Rare Earth Element Purification
 
 
American Resources (NASDAQ: AREC) to Report First Quarter of 2021 Earnings on May 12, 2021
 
 
Recruiter.com's (OTCQB: RCRT) Recruiter Index(R) to be Featured on CNBC for 12th Consecutive Month
 
 
CBD of Denver (OTC: CBDD) Provides Update on Swiss Pilot Program Permitting Temporary Production and Sale of Marijuana
 
 
CBD of Denver’s (OTC: CBDD) Rockflowr Reports Record Revenue of $24.4M for the Trailing 12-Months Ended April 2021
 
 
CBD of Denver (OTC: CBDD) Engages Skyrocket to Drive Sales Through New Direct-to-Consumer Ecommerce Marketing Program
 
 
 
Upcoming Zoom Webinar
 
 
 
 
 
 

Join Zoom Meeting: zoom.us/j/92124350712
Or iPhone one-tap : US: +13017158592,,96924608241#,,,,*688926# or +13126266799,,96924608241#,,,,*688926#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 969 2460 8241
Passcode: 688926
International numbers available:
zoom.us/u/asVTzvaQS


 
 
 
 
 
 
 
Quote of the Week
 
"You can’t be right all the time, but you can surround yourself with honest people."
- John Pappajohn, Venture Capitalist
 
 
 
Lesson of the Week
 
Leadership makes or breaks companies.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: Two Small-Cap Stocks Under Wall Street’s Radar
 
This week’s episode of the RedChip Money Report features interviews with senior executives from Tiziana Life Sciences (NASDAQ: TLSA) and Amesite (NASDAQ: AMST). Visit RedChip.com to learn more.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming the Global Financial System
 
Led by co-founders Wouter Witvoet and Olivier Roussy Newton, who collectively raised $1.4B in their prior two deals, DeFi Technologies (OTC: DEFTF) is well positioned to become a key player in the rapidly growing decentralized finance industry. The market size for the industry is measured in the trillions and spans multiple sectors, including insurance, derivatives, credit and lending, asset management, and exchanges.
 
Watch Now
 
 
 
 
Amesite: AI-Driven EdTech Transforming Learning
 
Amesite (Nasdaq: AMST) is an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education. The Company leverages existing institutional infrastructures, adding mass customization and cutting-edge technology to provide cost-effective, scalable, and engaging experiences for learners anywhere.
 
Watch Now
 
 
 
 
CBD of Denver Interviewed on Benzinga’s Cannabis Insider
 
CBD of Denver (CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Tiziana Life Sciences: Robust Pipeline with Multiple Near-Term Catalysts
 
Tiziana Life Sciences (NASDAQ: TLSA) has developed proprietary oral, nasal, and inhaled formulation technologies that could transform immunotherapies with Monoclonal Antibodies currently administered intravenously for multiple indications.
 
Watch Now
 
 
 
 
Milestone Scientific: Leading Injection Technology Innovator
 
Milestone Scientific (NYSE American: MLSS) is a leading medical research and development company that designs and patents innovative injection technology. The Company’s clinically validated, patented, computer-controlled systems make injections precise, efficient, and virtually painless, addressing unmet needs and providing a potential new standard of care in anesthesia.
 
Watch Now
 
 
 
 
Medalist Diversified REIT: Targeting Attractive Opportunities in Secondary Markets in Southeast U.S.
 
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions.
 
Watch Now
 
 
 
 
Recruiter.com: Transforming the World of Recruiting
 
Recruiter.com (OTCQB: RCRT) is a hiring platform for the world’s largest network of recruiters. Recruiter.com empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize an innovative web platform, complete with AI-driven job matching, screening and video interviewing to recruit talent faster.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming Global Finance
 
Led by co-founders Wouter Witvoet and Olivier Roussy Newton, who collectively raised $1.4B in their prior two deals, DeFi Technologies (OTC: DEFTF) is well positioned to become a key player in the rapidly growing decentralized finance industry. The market size for the industry is measured in the trillions and spans multiple sectors, including insurance, derivatives, credit and lending, asset management, and exchanges.
 
Watch Now
 
 
 
 
Virios Therapeutics: Potential Treatment Paradigm Shift for Fibromyalgia
 
Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as Fibromyalgia (“FM”).
 
Watch Now
 
 
 
 
Aptorum Group: Developing Novel Therapeutics for Unmet Medical Needs
 
Aptorum Group Limited (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases, and metabolic diseases.
 
Watch Now
 
 
 
 
EVmo: Leading Provider of Rental Vehicles for the Gig Economy
 
EVmo (OTC: YAYO) bridges the gap between rideshare drivers in need of a suitable vehicle and rideshare companies that depend on attracting and keeping drivers. EVmo uniquely supports drivers in both the higher and lower economic categories with innovative policies and programs. EVmo is a leading provider of rental vehicles to drivers in the ever-expanding gig economy.
 
Watch Now
 
 
 
 
Killi: Transforming the $247B Market for Personal Data
 
Founded in 2018 and with offices in New York & Toronto, Killi (TSXV: MYID; OTCQB: MYIDD) is a company driven by the evolution of data and privacy. Killi aims to democratize data for consumers by providing them with an ecosystem where they can view, edit, opt-out, and be compensated for the use of their data. Today there is no destination for consumers to participate in the use of their data. Killi aspires to be the destination that consumers visit to reclaim control of their online data.
 
Watch Now
 
 
 
 
Elixinol: Industry Pioneer Set for Rapid Growth
 
Elixinol (OTC: ELLXF) is an original pioneer in the CBD industry — focused on the science, research and development of world-class cannabinoid products that provide real results for real people. A global company with a proven track record of growing and extracting premium-quality hemp, Elixinol's products are sold online at Elixinol.com, at over 2,600 natural, specialty and conventional grocery stores and pharmacies across the U.S., and around the world.
 
Watch Now
 
 
 
 
BTCS: Pioneer in Blockchain Space
 
BTCS Inc. (OTCQB: BTCS) is an early entrant in the digital asset market and one of the first U.S. publicly traded companies focused on digital assets and blockchain technologies. BTCS resumed its transaction verification services business segment in the first quarter of 2021 with a focus on validating transactions and operating nodes on proof-of-stake blockchains.
 
Watch Now
 
 
 
 
Learn Why Robert Blair, The Visionary Architect Behind Lulu Lemon (LULU) Joined RYU Apparel
 
RYU Apparel (OTCQB: RYPPF), or Respect Your Universe, is an award winning urban athletic apparel brand that engages in the development, marketing, and distribution of apparel, bags and accessories. Our products are engineered for the fitness, training and performance of the multi-discipline athlete. Our products are designed, developed and tested at our corporate headquarters in Vancouver, BC, Canada. Production takes place in factories located in North America and Asia.
 
Watch Now
 
 
 
 
Lantern Pharma: Transforming Cancer Drug Development with A.I.
 
Lantern Pharma (Nasdaq: LTNR) is a clinical stage biotechnology company leveraging its RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug development. RADR® A.I. quickly and efficiently develops precise genetic signatures of disease that underpin the identification of patients for whom its portfolio of oncology drug candidates is likely to have the greatest therapeutic effect. Lantern is currently developing three drug candidates in solid tumors.
 
Watch Now
 
 
 
 
Kiromic BioPharma: AI-Driven Immuno-Oncology Therapy Development
 
Kiromic BioPharma (Nasdaq: KRBP) is revolutionizing next-generation allogenic CAR therapies for solid tumors. The Company’s proprietary target discovery engine, Diamond uses AI and a proprietary neural network to identify development targets, dramatically compressing man years and billions of drug development dollars required to develop new live drugs.
 
Watch Now
 
 
 
 
Aridis Pharmaceuticals: Developing Novel Anti-Infective Therapies
 
Aridis Pharmaceuticals (Nasdaq: ARDS) discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The Company is utilizing its proprietary ʎPEXTM and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbs) for therapeutic treatment of critical infections.
 
Watch Now
 
 
`
 
 
COMSovereign Corporate Overview with CEO & CTO
 
COMSovereign Holding (Nasdaq: COMS) Chairman & CEO Dan Hodges, along with Chief Technology Officer Dr. Dustin McIntire, share insight into the Company’s portfolio of communications technology companies and how they are expected to drive rapid growth in 2021 and beyond. Through strategic acquisitions and organic research and development efforts, COMSovereign has become a U.S.-based communications provider able to provide 4G LTE Advanced and 5G-NR telecom solutions to network operators and enterprises.
 
Watch Now
 
 
 
 
Hoth Therapeutics: Developing a New Generation of Therapies for Unmet Medical Needs
 
Hoth Therapeutics (Nasdaq: HOTH) is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth's clinical pipeline is concentrated on drug candidates that improve the quality of life for patients suffering from indications including atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, asthma, acne, mast-cell derived cancers & anaphylaxis and pneumonia.
 
Watch Now
 
 
 
 
Can-Fite BioPharma: Advanced Clinical Stage Drug Development
 
Can-Fite BioPharma (NYSE American: CANF) has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases. The company’s platform technology utilizes the Gi protein associated A3 adenosine receptor (A3AR) as a therapeutic target. A3AR is highly expressed in inflammatory and cancer cells where low expression is found in normal cells, suggesting that the receptor could be a unique target for pharmacological intervention.
 
Watch Now
 
 
 
 
Esports Entertainment Group CEO Discusses Plans for Rapid Growth
 
Interview with CEO of Esports Entertainment Group Inc. (NASDAQ: GMBL), a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Its mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together. Esports Entertainment Group and its affiliates are well-poised to help fans and players to stay connected and involved with their favorite esports.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Commodity prices surged last week with both copper and lumber hitting record highs.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.